• Title of article

    Secondary Cancer Risk of Radiotherapy and Imaging Examination for Two Different Malignancies in One Patient

  • Author/Authors

    Zare ، Mohammad Hosein Department of Medical Physics - Shahid Sadoughi University of Medical Sciences and Health Services , Masjedi ، Hamidreaza Department of Medical Physics - Shahid Sadoughi University of Medical Sciences and Health Services , Tabatabaee ، Fateme Department of Clinical Radiology - Shahid Sadoughi University of Medical Sciences , Rahbar Yazdi ، Shiva Department of Medical Physics - Shahid Sadoughi University of Medical Sciences and Health Services , Shabani ، Masoud Clinical Oncology Department - Shahid Ramazan Zadeh Clinic - Shahid Sadoughi University of Medical Sciences , Broomand ، Mohammad Ali Clinical Oncology Department - Shahid Ramazan Zadeh Clinic - Shahid Sadoughi University of Medical Sciences

  • From page
    496
  • To page
    502
  • Abstract
    Purpose: Radiotherapy (RT), which is considered one of the critical treatments for cancer patients is also known as adjuvant therapy and palliative care, and can be attempted alone or concurrent with chemotherapy. Although RT reduces the risk of recurrence, the scattered dose may enhance the risk of secondary cancer induction; this is raising some challenges in clinical practice. To the best of our knowledge, few studies to date have assessed such effects of brain cancer adjuvant radiotherapy. Materials and Methods: We estimated the RT-induced risk of secondary cancer for a 45-year-old patient who had undergone radiotherapy of the head and pelvis with a 6 MV photon beam in 15 and 10 sessions, respectively. The absorbed dose by the thyroid, breast, eye lenses, region overlying ovaries, and parotids was measured using Thermoluminescent Dosimeters (TLD). Since the patient was scanned before radiotherapy, it was decided to calculate their risk as well. To evaluate the cancer risk, radiobiological models for Excess Absolute Risk (EAR), as well as Excess Relative Risk (ERR) published by the Committee on the Biological Effects of Ionizing Radiation (BEIR) in report VII, were implemented. This study thus aimed to estimate the Risk of Exposure-Induced Death (REID) and assess the radiation dose delivered to patients from Computed Tomography (CT) scans and common diagnostic nuclear medicine examinations Results: The mean risk of secondary cancer for sensitive organs was calculated 3 years after radiotherapy. The highest estimated ERR was related to the region overlying right and left ovaries for pelvic radiotherapy (47.82) and (51.17), and the next highest EAR followed by right and left eye lenses for brain radiotherapy (18.09) and (15.43), respectively. In addition, other cancers arising from CT scans had the highest REID values for solid cancer (0.0015) and bone scans revealed the highest REID values for other cancers (0.00121). Conclusion: Calculating the corresponding risks of RT is of great significance for the patients in procedural change. Choosing proper field sizes and adapted techniques to avoid excessive doses to healthy organs can thus be a great assistance in this regard.
  • Keywords
    Radiotherapy , Cancer Risk , Thermoluminescent Dosimeters , Organ Dose
  • Journal title
    Frontiers in Biomedical Technologies
  • Journal title
    Frontiers in Biomedical Technologies
  • Record number

    2757716